278 related articles for article (PubMed ID: 4911592)
1. Therapeutic activity of 4-allyloxy-3-chlorophenylacetic acid.
Lambotte F
Arzneimittelforschung; 1970 Apr; 20(4):569-71. PubMed ID: 4911592
[No Abstract] [Full Text] [Related]
2. Treatment of articular and non-articular (rheumatic diseases by indomethacin suppositories).
Vaishnava H; Dasgupta MK; Sachar MS
J Assoc Physicians India; 1971 Feb; 19(2):157-65. PubMed ID: 4934419
[No Abstract] [Full Text] [Related]
3. Double-blind comparison between 4-allyloxy-3-chlorophenylacetic acid (alclofenac) and phenylbutazone in osteoarthritis.
Van Hoek J
Curr Ther Res Clin Exp; 1970 Sep; 12(9):551-5. PubMed ID: 4989683
[No Abstract] [Full Text] [Related]
4. Pharmacology of a new analgesic, antipyretic, and anti-inflammatory agent, 4-allyloxy-3-chlorophenylacetic acid.
Lambelin G; Roba J; Gillet C; Buu-Hoï NP
Arzneimittelforschung; 1970 May; 20(5):610-8. PubMed ID: 4987564
[No Abstract] [Full Text] [Related]
5. Analgesics and non-steroid anti-inflammatory agents in rheumatic disease.
Hart FD
Practitioner; 1972 Jan; 208(243):10-7. PubMed ID: 4536903
[No Abstract] [Full Text] [Related]
6. A multicentre trial of Voltaren in the treatment of rheumatoid Arthritis.
Meyers OL; Quantock OP; Joubert PG; Louw DFDP ; Marais DF; McDonald Scott WA; Müller FO
S Afr Med J; 1974 Oct; 48(48):2013-7. PubMed ID: 4612752
[No Abstract] [Full Text] [Related]
7. [Effects and side effects of 3-chlor-4-allyloxy-phenylacetic acid (Mervan) in therapeutic study of rheumatic diseases].
Klemm C; Fricke R; Schattenkirchner M; Treiber W; Mathies H
Z Rheumaforsch; 1971; 30(1):17-25. PubMed ID: 5315910
[No Abstract] [Full Text] [Related]
8. [2-(4-Isobutylphenyl)-propionic acid in the treatment of rheumatic diseases: clinical effects and tolerance].
Viara M
Minerva Med; 1973 Jun; 64(47):2513-4. PubMed ID: 4579843
[No Abstract] [Full Text] [Related]
9. [Statistical evaluation of the therapeutic action of a new anti-rheumatic: 4-isobutyl-phenyl-acetic acid (Ibufenac) in the treatment of rheumatoid arthritis].
Chériè Lignière G; Colombo B; Carrabba M
Reumatismo; 1969; 21(3):97-104. PubMed ID: 4929606
[No Abstract] [Full Text] [Related]
10. Alclofenac in rheumatoid arthritis: an evaluation of its anti-inflammatory and analgesic effects.
Aylward M
Br J Clin Pract; 1973 Jul; 27(7):255-60. PubMed ID: 4580332
[No Abstract] [Full Text] [Related]
11. [Therapeutic effects of non-steroid anti-inflammatory agents, with special reference to 2-4(4-isobutylphenyl)-propionic acid].
Cremoncini C; Mola V
Minerva Med; 1973 Jun; 64(46):2423-35. PubMed ID: 4579327
[No Abstract] [Full Text] [Related]
12. [Results of clinical trials of calcium bucloxate (804 CB) in rheumatology].
de Sèze S; Dryll A; Dreiser R
Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1425-8. PubMed ID: 4614819
[No Abstract] [Full Text] [Related]
13. [On the evaluation of the effect of a combination of salicylates and prednisolone in rheumatic diseases].
Schoger GA
Arzneimittelforschung; 1968 Jun; 18(6):758-60. PubMed ID: 4885097
[No Abstract] [Full Text] [Related]
14. [Clinical observations on the treatment of rheumatic diseases and other morbid states with indomethacin].
Fusco FA; Azzolini A; Dolcino G
Minerva Med; 1966 Nov; 57(92):3880-90. PubMed ID: 5297049
[No Abstract] [Full Text] [Related]
15. [Antirheumatics in a narrower sense].
Gross D
Ther Umsch; 1972 Aug; 29(8):502-4. PubMed ID: 4538298
[No Abstract] [Full Text] [Related]
16. [Mervan (4-allyloxy-3-chlorphenylacetic acid) in the therapy of chronic progressive polyarthritis].
Pavelka K; Kanková D; Wagenhäuser F; Böni
Z Rheumaforsch; 1971; 30(1):50-6. PubMed ID: 5123100
[No Abstract] [Full Text] [Related]
17. Toxicity studies of 4-allyloxy-3-chlorophenylacetic acid, a new analgesic, antipyretic, and anti-inflammatory agent.
Lambelin G; Roba J; Gillet C; Gautier M; Buu-Hoï NP
Arzneimittelforschung; 1970 May; 20(5):618-30. PubMed ID: 4987565
[No Abstract] [Full Text] [Related]
18. [Interactions of nonsteroid anti-inflammatory drugs with inhibitors of angiotensin-converting enzyme in patients with rheumatic diseases (a review)].
Tsurko VV; Preobrazhenskiĭ DV; Ob ukhova OA
Ter Arkh; 2003; 75(5):64-70. PubMed ID: 12847902
[No Abstract] [Full Text] [Related]
19. A double-blind crossover trial comparing a new antirheumatic agent alclofenac with phenylbutazone in chronic rheumatic disorders.
Anylward M; Davies DB
Br J Clin Pract; 1972 Nov; 26(11):517-23. PubMed ID: 4563533
[No Abstract] [Full Text] [Related]
20. [Clinical study of oral and parenteral alclofenac in acute rheumatic disorders].
Ory M
Brux Med; 1971 Sep; 51(9):615-9. PubMed ID: 5315686
[No Abstract] [Full Text] [Related]
[Next] [New Search]
